BioPerfectus supports the World Health Organization (WHO) Global Cervical Cancer Elimination Initiative, unwavering in its commitment to women's health.
At the Medical Microbiologists’ Paying Homage & Prize Giving Ceremony, held on Saturday, December 23, 2023, at the Park Royal Hotel in Yangon, Myanmar, we at BioPerfectus, in collaboration with our esteemed business partners, took pride in presenting our extensive range of diagnostic solutions.
BioPerfectus offers full genotypes RT-PCR testing solutions for avian influenza and zoonotic influenza based on human specimens.
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and health departments about the occurrence, geographic spread, and sexually associated human-to-human transmission of Clade I Monkeypox virus (MPXV) in the Democratic Republic of the Congo (DRC) on December 7, 2023.
On December 7, 2023, BioPerfectus successfully obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS) with registration number CNAS L19654.
BioPerfectus was honored to host a distinguished delegation, including representatives from the Bill & Melinda Gates Foundation, PATH, Global Health Labs (GHLabs), and the Clinton Health Access Initiative (CHAI).
BioPerfectus extends a heartfelt welcome to the delegation led by the Consul General of Chile in Shanghai at Tai Zhou, Jiangsu, China.
BioPerfectus is committed to ongoing technological innovation and proudly offers the HPV 21 Type-specific Viral Loads Detection System to the world.
Dengue fever will become a major threat in the southern United States, southern Europe, and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.
BioPerfectus made a notable impression at the 20th Members' Meeting of the RHSC.
